These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7081257)

  • 1. Analog-computer method for rapid estimates of theophylline clearance using presteady-state plasma concentrations.
    Errick JK
    Am J Hosp Pharm; 1982 May; 39(5):829-31. PubMed ID: 7081257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
    Paterson CM; Hudson SA; Jefferson GC
    J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System for clinical pharmacokinetic monitoring of theophylline therapy.
    Koup JR; Schentag JJ; Vance JW; Kuritzky PM; Pyszczynski DR; Jusko WJ
    Am J Hosp Pharm; 1976 Sep; 33(9):949-56. PubMed ID: 790952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of theophylline clearance using condition correction factors.
    Haumschild MJ; Murphy JE
    Clin Pharm; 1985; 4(1):59-64. PubMed ID: 3971684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A system for individualized dosing of intravenous aminophylline using a programmable calculator.
    Mitsuoka JC; Fleck RJ
    Pediatrics; 1984 Jan; 73(1):64-7. PubMed ID: 6546320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL; Passos-Coelho JL; Noe DA; Kennedy MJ; Black KC; Colvin OM; Grochow LB
    Cancer Res; 1995 Feb; 55(4):810-6. PubMed ID: 7850794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microprocessor-programmed infusion of theophylline rapidly attained expected steady-state level in rabbit plasma.
    Duan SM; Xu X; Ye M; Fu Y
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):403-7. PubMed ID: 7717061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic study of theophylline in dogs after intravenous administration with and without ethylenediamine.
    Kawai H; Kokubun S; Matsumoto T; Kojima J; Onodera K
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):179-84. PubMed ID: 10893702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analog computer monitoring and evaluation of a dosing nomogram for gentamicin based on the c'min-method: Part I.
    Ritschel WA; Banarer M; Diaz D; Margary JB; Otero JD
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):425-30. PubMed ID: 7203718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age and sex on theophylline clearance in young subjects.
    Gardner MJ; Jusko WJ
    Pediatr Pharmacol (New York); 1982; 2(2):157-69. PubMed ID: 12760407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequacy of recommended aminophylline loading doses in children.
    Maxwell-Rubin M; Paap CM; Godley PJ
    Am J Hosp Pharm; 1994 Jul; 51(13):1667-71. PubMed ID: 7942891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cimetidine on the pharmacokinetics of theophylline.
    Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
    Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.